TITLE

What is the prevalence of prostate cancer among men with low prostate-specific antigen levels?

AUTHOR(S)
Alibhai, Shabbir M. H.
PUB. DATE
September 2004
SOURCE
CMAJ: Canadian Medical Association Journal;9/14/2004, Vol. 171 Issue 6, p572
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Presents information on a study which investigated the prevalence of prostate cancer among men with low prostate-specific antigen levels. Methodology; Results; Practice implications.
ACCESSION #
14325855

 

Related Articles

  • Ending the exam men hate. O'Keefe, Brian // Fortune;1/7/2002, Vol. 145 Issue 1, p55 

    Discusses the pros and cons of the blood test for a substance called prostate-specific antigens (PSA) which provides early clues in the diagnosis of prostate cancer. Prostate cancer as the most commonly diagnosed form of cancer in the United States after skin cancer; Factors which may increase...

  • Rate of PSA Rise Associated With Risk of Death from Prostate Cancer. L.#Zielinski, Sarah; Travis, Kate // JNCI: Journal of the National Cancer Institute;8/4/2004, Vol. 96 Issue 15, p1127 

    Reports on the findings of a study about the association of rapid increased in prostate-specific antigen levels with risk of death from prostate cancer. Spread of tumor; Increased risk of dying even after prostatectomy; Relative risk of death.

  • PSA doubling time and time to biochemical failure may predict prostate cancer-specific mortality.  // Hem/Onc Today;11/25/2008, Vol. 9 Issue 21, p44 

    The article discusses research on the prediction of prostate cancer-specific mortality through time to biochemical failure and prostate-specific antigen (PSA) doubling time. It references a study published in a 2008 issue of "Lancet Oncology." The research has found that PSA doubling time was...

  • Repeating an abnormal prostate-specific antigen (PSA) level: how relevant is a decrease in PSA? Connolly, D.; Black, A.; Murray, L. J.; Nambirajan, T.; Keane, P. F.; Gavin, A. // Prostate Cancer & Prostatic Diseases;2009, Vol. 12 Issue 1, p47 

    To examine the practice of repeating an abnormal prostate-specific antigen (PSA) level before proceeding to prostate biopsy, we assessed the pattern of PSA change following an initially raised (4.0 ng ml−1) PSA, and the relationship of this to prostate cancer diagnosis. In 7052 men,...

  • BODY MASS INDEX AFFECTS THE DIAGNOSIS AND PROGRESSION OF PROSTATE CANCER IN HISPANICS. Negrón, Rosa; Vásquez, Andrea; Nieves, Mariely; Guerrios, Lourdes; Irizarry-Ramírez, Margarita // Ethnicity & Disease;Winter2010 Supplement, Vol. 20, pS1-168 

    Introduction: The occurrence of lower prostate-specific antigen (PSA) levels in overweight White and African American men has been studied, but there is no data regarding Hispanics, which have a higher mortality rate from Prostate Cancer (PCa) than Whites. The objective of this study was to...

  • A Normal PSA Doesn't Always Mean Cancer Free.  // RN;Aug2004, Vol. 67 Issue 8, p18 

    Reports on the findings of a study showing that some men with a normal prostate-specific antigen (PSA) level may still have prostate cancer. Rate of prostate cancer among men ages 62-91 who were part of a large study of prostate cancer treatment; Results of biopsies; Relation between lowering...

  • Proteome terminates development of prostate cancer test.  // PharmaWatch: Cancer;Sep2008, Vol. 7 Issue 9, p14 

    The article reports that Proteome Systems Ltd. has terminated its study which assesses the potential of human carcinoma antigen (HCA) as a semen-based marker for diagnosing prostate cancer. It reveals that the decision was made brought by the longer time needed to develop an assay for HCA...

  • Screening for Prostate Cancer Using Prostate-specific Antigen Alone as a First-line Checkup Parameter: Results of the Health Checkup System. Uchida, Katsunori; Takeshima, Hitoshi; Akaza, Hideyuki; Ono, Yukio // Japanese Journal of Clinical Oncology;Feb2000, Vol. 30 Issue 2 

    Discusses the results of primary prostrate cancer screening using serum prostrate-specific antigen (PSA) levels in a health checkup system in Japan. Cut-off value for PSA; Detection rates of prostrate cancer; Screening by digital rectal examination and transrectal ultrasonography; Usefulness of...

  • Rapid PSA rise predicts cancer.  // Cortlandt Forum;9/25/2004, Vol. 17 Issue 9, p19 

    Highlights the results of the study conducted at the Harvard Medical School in Boston, Massachusetts revealing that a rapid increase in prostate-specific antigen levels may heighten risk to prostate cancer mortality. Design of the study; Rate of the risk of re-occurrence; Determination of the...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics